MedTrace Logo

Cardiac Power Output in Cardiogenic Shock Patients

NCT05700617 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-07-08

No results posted yet for this study

Summary

The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.

Conditions

Interventions

DRUG

1:1 Randomization to receive milrinone

Randomized to receive either inotropic agent: milrinone or no agent

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Valluvan Jeevanandam, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-06
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05700617 on ClinicalTrials.gov